Lymphoma / Leukemia News From Medical News TodayLatest Lymphoma / Leukemia News From Medical News Today.Vote Now For The 2008 Beacons Of Hope Awards, Lymphoma Association, UK- July 31, 2008 The Lymphoma Association, the only specialist UK charity that provides medical information and support to lymphatic cancer patients, their families and friends, is calling for nominations for their annual Beacons of Hope Awards. As Julie Mercer, Head of Communications for the charity says: "The awards are part of the activities for World Lymphoma Awareness Day - which is celebrated annually on September 15.http://www.medicalnewstoday.com/articles/116789.php Unexpected Benefit Of Allergies- July 31, 2008 Long-suffering victims of allergies such as asthma and hay fever might enjoy a surprise benefit, according to research led by the University of New South Wales (UNSW). In a paper presented at an international symposium in Sydney, the researchers show that people with one of these atopic diseases are up to 25 percent less likely to get the most common type of Non-Hodgkin Lymphoma (NHL).http://www.medicalnewstoday.com/articles/116643.php Amendment For ELACYT Clinical Program Following Evaluation Of All Clinical Data Available For ELACYT(TM), Both In Haematology And Solid Tumours- July 30, 2008 "We are now focusing our clinical trials with ELACYT primarily on haematological cancers reflecting our recently gained in-depth knowledge of certain important cellular uptake mechanisms, whilst we continue to evaluate the clinical activity of an intense dosing regimen in ovarian cancer ", says Geir Christian Melen, CEO of Clavis Pharma.http://www.medicalnewstoday.com/articles/116609.php Polyphenon Pharma Receives Orphan Drug Designation For Its Botanical Drug, Polyphenon E, For The Treatment Of CLL- July 29, 2008 Polyphenon Pharma, an emerging research-based pharmaceutical company, announced that the Food and Drug Administration (FDA) has granted Orphan Drug Designation to its botanical drug, Polyphenon E(R), for the treatment of chronic lymphocytic leukemia (CLL). A Phase II study is currently underway at the Mayo Clinic in Rochester, Minnesota where researchers are studying the effects of an oral daily dose of Polyphenon E in CLL patients.http://www.medicalnewstoday.com/articles/116391.php Ceplene Receives Positive European Opinion For Approval From CHMP - Acute Myeloid Leukemia- July 27, 2008 EpiCept Corporation (Nasdaq and OMX Nordic Exchange: EPCT) announced today that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMEA) has issued a positive opinion regarding the marketing authorization for Ceplene (histamine dihydrochloride), for the remission maintenance and prevention of relapse in adult patients with Acute Myeloid Leukemia (AML) in first remission.http://www.medicalnewstoday.com/articles/116199.php Shortage Of Cancer Drugs Impacts Iraqi Children With Leukemia- July 25, 2008 A study led by Vanderbilt-Ingram Cancer Center researchers revealed that some Iraqi children diagnosed with leukemia paid a steep price for economic sanctions imposed by the United Nations against the Iraqi government. The U.N.-ordered sanctions were imposed in 1990 after the invasion of Kuwait and remained in effect until 2003. During the sanctions, there was a widespread shortage of medications, including antibiotics and chemotherapeutic drugs.http://www.medicalnewstoday.com/articles/116114.php Immunotherapy With Leukemia-cell-derived Heat Shock Protein 70 Triggers Induction Of Leukemia-specific Antibodies- July 24, 2008 Even after chemotherapies and stem cell transplants, relapses still occur in leukemia patients. This study established a mouse model after bone marrow transplant and found that the immunization of mice with leukemia-cell-derived heat shock protein 70 (HSP) induced leukemia-specific immunities and prolonged their survival. The tumor-derived-HSP binds the tumor-specific antigenic peptides, making it an effective cancer vaccination.http://www.medicalnewstoday.com/articles/115938.php CTI To Meet With The FDA To Discuss Filing Of A Supplemental Biologics License Application For Zevalin(R)- July 23, 2008 Cell Therapeutics, Inc. (CTI) (Nasdaq and MTA: CTIC) announced that the Company has scheduled a meeting with the U.S. Food and Drug Administration (FDA) in September to discuss the possibility of filing a supplemental Biologics License Application (sBLA) for use of Zevalin(R) (90Y-ibritumomab tiuxetan) as consolidation therapy after remission induction in previously untreated patients with follicular non-Hodgkin's lymphoma.http://www.medicalnewstoday.com/articles/115863.php Plants Make Vaccine For Treating Type Of Cancer, Stanford Study- July 23, 2008 Plants could act as safe, speedy factories for growing antibodies for personalized treatments against a common form of cancer, according to new findings from the Stanford University School of Medicine. The findings came in the first human tests of an injectable vaccine grown in genetically engineered plants.http://www.medicalnewstoday.com/articles/115806.php Tobacco Used To Make Cancer Vaccine- July 22, 2008 In an ironic twist to the relationship between tobacco and human health, it would seem that the future of the plant may lie in growing vaccines against cancer. Researchers in the US took antibodies from patients with a type of lymphoma, grew them in tobacco plants, extracted them, and reinjected the individualized vaccines back into the patients, where in most cases it produced an immune response that helped to fight the cancer.http://www.medicalnewstoday.com/articles/115826.php |